28
Participants
Start Date
July 9, 2019
Primary Completion Date
October 3, 2019
Study Completion Date
Padsevonil
Padsevonil will be administered in predefined dosages.
Up0053 001, San Antonio
UCB Biopharma S.P.R.L.
INDUSTRY